AWS AI Watch posted an update
Australian biotech CSL says it is working with Amazon Web Services to use cloud computing and AI in drug research and clinical development, BigGo Finance reports.
Why it mattersThe proposed uses include analysing scientific data to find potential drug targets earlier, and reducing manual work on clinical-trial protocols, data management and regulatory submissions. CSL says it will maintain data governance and traceability. That makes this a concrete example of AI being put to work across both laboratory research and clinical administration. The report gives no timeline or measured results yet, so the promised acceleration remains just that.
Discuss: Should drug companies prioritise AI for finding new targets, or for taking paperwork out of clinical development?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.